Role of Intronic Variants Affecting Splicing in Juvenile Myoclonic Epilepsy

影响剪接的内含子变异在青少年肌阵挛性癫痫中的作用

基本信息

  • 批准号:
    8133221
  • 负责人:
  • 金额:
    $ 2.14万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2012-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Juvenile Myoclonic Epilepsy (JME) is among the most common types of syndromes of Idiopathic Generalized Epilepsy (IGE) and has a complex genetic inheritance. Although several putative JME susceptibility genes have been identified, the functions of these genes in the brain and their roles in the pathogenesis of seizures are unknown. Linkage and association analysis led us to the bromodomain-containing gene BRD2. BRD2 is a member of BET subfamily of double bromodomain-containing genes implicated in regulating gene expression. We have shown that BRD2 is expressed in developing and adult brain, and recently, that Brd2-null embryos die at mid-gestation with central nervous system malformations. Further, our preliminary data show that heterozygous Brd2 mice exhibit a reduction in the number of GABAergic interneurons in the frontal cortex and, strikingly, heterozygous Brd2 mice exhibit an enhanced sensitivity to chemically-induced seizures. Our working hypothesis is that mis-expression of BRD2 contributes to seizure susceptibility. We have also discovered that intron 2 of BRD2 contains a highly conserved, alternatively spliced exon, which introduces a premature termination codon and we have identified polymorphisms in the lengths of CA-repeats in intron 2 that are associated with JME. Variation in the length of CA-repeats has been shown to affect alternative splicing events in other experimental models. We now wish to test the hypothesis that the polymorphisms in intron 2, in particular variants in CA repeat-length that we have identified in patient DNA that associate with JME, affect splicing of the alternative exon and the levels of the corresponding transcripts, and hence, function of BRD2 products. In Aim 1, we will initially examine the effect of variable CA-repeat lengths on the relative levels of the two alternatively spliced BRD2 transcripts by transient expression of 'mini-gene' constructs containing [exon 2]-[intron 2]-[exon3] of human BRD2 with varying CA-repeat lengths and measuring the ratio of the resulting two transcripts. In Aim 2, we will begin to elucidate the functional significance of the alternatively spliced transcripts by determining whether the alternative transcripts are translated and if so, whether the proteins made affect homodimerization or sub-cellular localization. PUBLIC HEALTH RELEVANCE: Juvenile Myoclonic Epilepsy (JME) is among the most common types of syndromes of Idiopathic Generalized Epilepsy (IGE) and is characterized by adolescent onset and life-long affliction, requiring continual medication to suppress seizures. The proposed experiments will demonstrate whether the JME- associated variants in intron 2 of BRD2 play a direct role in the frequency of alternative splicing, and further, will provide insight into the possible physiological significance of the alternative transcripts, outcomes that are highly relevant to the stated goals of the RFA and the R03 funding mechanism.
描述(申请人提供):青少年肌阵挛癫痫(JME)是特发性全身性癫痫(IGE)最常见的综合征类型之一,具有复杂的遗传。虽然已经鉴定了几个可能的JME易感基因,但这些基因在大脑中的功能及其在癫痫发病机制中的作用尚不清楚。连锁和关联分析使我们找到了含溴结构域的基因BRD2。Brd2是双溴结构域基因的BET亚家族成员,参与基因表达调控。我们已经证明,BRD2在发育中的大脑和成年大脑中都有表达,最近,BrD2缺失的胚胎在妊娠中期死亡,并伴有中枢神经系统畸形。此外,我们的初步数据显示,杂合的Brd2小鼠显示出额叶皮质中GABA能中间神经元的数量减少,令人惊讶的是,杂合的Brd2小鼠对化学诱导的癫痫发作表现出更高的敏感性。我们的工作假设是BRD2的错误表达与癫痫易感性有关。我们还发现BRD2的内含子2含有一个高度保守的、选择性剪接的外显子,它引入了一个提前终止密码子,我们还发现了与JME相关的内含子2中CA重复序列长度的多态。在其他实验模型中,CA-重复序列长度的变化已被证明影响选择性剪接事件。我们现在希望检验这样的假设,即内含子2的多态,特别是我们在患者DNA中发现的与JME相关的CA重复长度变异,影响替代外显子的剪接和相应转录本的水平,从而影响BRD2产物的功能。在目标1中,我们将通过瞬时表达含有不同CA-重复长度的人BRD2的[外显子2]-[内含子2]-[外显子3]的‘mini基因’结构,并测量产生的两个转录本的比例,初步检测可变的CA-重复长度对两个选择性剪接的BRD2转录本的相对水平的影响。在目标2中,我们将通过确定选择性转录本是否被翻译以及如果是的话,所产生的蛋白质是否影响同源二聚化或亚细胞定位来阐明选择性剪接转录本的功能意义。 公共卫生相关性:青少年肌阵挛癫痫(JME)是特发性全身性癫痫(IGE)最常见的综合征类型之一,其特点是青春期发作和终生痛苦,需要持续用药来抑制癫痫发作。拟议的实验将证明BRD2内含子2中的JME相关变体是否在替代剪接的频率中发挥直接作用,并进一步提供对替代转录本可能的生理意义的洞察,这些结果与RFA和R03资助机制的声明目标高度相关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEBRA J. WOLGEMUTH其他文献

Recombination intermediates (reply)
重组中间体(回复)
  • DOI:
    10.1038/289097d0
  • 发表时间:
    1981-01-01
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    DEBRA J. WOLGEMUTH;MING-TA Hsu
  • 通讯作者:
    MING-TA Hsu

DEBRA J. WOLGEMUTH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEBRA J. WOLGEMUTH', 18)}}的其他基金

Function of the Bromodomain Protein Brdt in Spermatogenesis
Bromodomain 蛋白 Brdt 在精子发生中的功能
  • 批准号:
    7810433
  • 财政年份:
    2010
  • 资助金额:
    $ 2.14万
  • 项目类别:
Retinoid receptor antagonists as novel male contraceptives
类维生素A受体拮抗剂作为新型男性避孕药
  • 批准号:
    8056646
  • 财政年份:
    2009
  • 资助金额:
    $ 2.14万
  • 项目类别:
Role of Intronic Variants Affecting Splicing in Juvenile Myoclonic Epilepsy
影响剪接的内含子变异在青少年肌阵挛性癫痫中的作用
  • 批准号:
    7941948
  • 财政年份:
    2009
  • 资助金额:
    $ 2.14万
  • 项目类别:
Retinoid receptor antagonists as novel male contraceptives
类维生素A受体拮抗剂作为新型男性避孕药
  • 批准号:
    7626133
  • 财政年份:
    2009
  • 资助金额:
    $ 2.14万
  • 项目类别:
Role of Intronic Variants Affecting Splicing in Juvenile Myoclonic Epilepsy
影响剪接的内含子变异在青少年肌阵挛性癫痫中的作用
  • 批准号:
    7713471
  • 财政年份:
    2009
  • 资助金额:
    $ 2.14万
  • 项目类别:
Retinoid Receptor Antagonists as Novel Male Contraceptives
类维生素A受体拮抗剂作为新型男性避孕药
  • 批准号:
    8726695
  • 财政年份:
    2009
  • 资助金额:
    $ 2.14万
  • 项目类别:
Retinoid Receptor Antagonists as Novel Male Contraceptives
类维生素A受体拮抗剂作为新型男性避孕药
  • 批准号:
    9055741
  • 财政年份:
    2009
  • 资助金额:
    $ 2.14万
  • 项目类别:
Retinoid receptor antagonists as novel male contraceptives
类维生素A受体拮抗剂作为新型男性避孕药
  • 批准号:
    8228075
  • 财政年份:
    2009
  • 资助金额:
    $ 2.14万
  • 项目类别:
Retinoid receptor antagonists as novel male contraceptives
类维生素A受体拮抗剂作为新型男性避孕药
  • 批准号:
    8537001
  • 财政年份:
    2009
  • 资助金额:
    $ 2.14万
  • 项目类别:
Retinoid receptor antagonists as novel male contraceptives
类维生素A受体拮抗剂作为新型男性避孕药
  • 批准号:
    8427386
  • 财政年份:
    2009
  • 资助金额:
    $ 2.14万
  • 项目类别:

相似海外基金

Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 2.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The impact of changes in social determinants of health on adolescent and young adult mental health during the COVID-19 pandemic: A longitudinal study of the Asenze cohort in South Africa
COVID-19 大流行期间健康社会决定因素的变化对青少年和年轻人心理健康的影响:南非 Asenze 队列的纵向研究
  • 批准号:
    10755168
  • 财政年份:
    2023
  • 资助金额:
    $ 2.14万
  • 项目类别:
A Priority Setting Partnership to Establish a Patient, Caregiver, and Clinician-identified Research Agenda for Adolescent and Young Adult Cancer in Canada
建立优先合作伙伴关系,以建立患者、护理人员和临床医生确定的加拿大青少年和年轻人癌症研究议程
  • 批准号:
    480840
  • 财政年份:
    2023
  • 资助金额:
    $ 2.14万
  • 项目类别:
    Miscellaneous Programs
Incidence and Time on Onset of Cardiovascular Risk Factors and Cardiovascular Disease in Adult Survivors of Adolescent and Young Adult Cancer and Association with Exercise
青少年和青年癌症成年幸存者心血管危险因素和心血管疾病的发病率和时间以及与运动的关系
  • 批准号:
    10678157
  • 财政年份:
    2023
  • 资助金额:
    $ 2.14万
  • 项目类别:
Fertility experiences among ethnically diverse adolescent and young adult cancer survivors: A population-based study
不同种族青少年和年轻成年癌症幸存者的生育经历:一项基于人群的研究
  • 批准号:
    10744412
  • 财政年份:
    2023
  • 资助金额:
    $ 2.14万
  • 项目类别:
Treatment development for refractory leukemia using childhood/adolescent, and young adult leukemia biobank
利用儿童/青少年和青年白血病生物库开发难治性白血病的治疗方法
  • 批准号:
    23K07305
  • 财政年份:
    2023
  • 资助金额:
    $ 2.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular design of Two-Way Player CAR-T cells to overcome disease/antigen heterogeneity of childhood, adolescent, and young adult cancers
双向 CAR-T 细胞的分子设计,以克服儿童、青少年和年轻成人癌症的疾病/抗原异质性
  • 批准号:
    23H02874
  • 财政年份:
    2023
  • 资助金额:
    $ 2.14万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Effects of adolescent social isolation on adult decision making and corticostriatal circuitry
青少年社会隔离对成人决策和皮质纹状体回路的影响
  • 批准号:
    10756652
  • 财政年份:
    2023
  • 资助金额:
    $ 2.14万
  • 项目类别:
Adolescent trauma produces enduring disruptions in sleep architecture that lead to increased risk for adult mental illness
青少年创伤会对睡眠结构产生持久的破坏,从而导致成人精神疾病的风险增加
  • 批准号:
    10730872
  • 财政年份:
    2023
  • 资助金额:
    $ 2.14万
  • 项目类别:
Using Tailored mHealth Strategies to Promote Weight Management among Adolescent and Young Adult Cancer Survivors
使用量身定制的移动健康策略促进青少年和年轻癌症幸存者的体重管理
  • 批准号:
    10650648
  • 财政年份:
    2023
  • 资助金额:
    $ 2.14万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了